| A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach E Encinas, R Calvo, JC Lukas, V Vozmediano, M Rodriguez, E Suarez Pediatric drugs 15, 247-257, 2013 | 40 | 2013 |
| Physiologically based pharmacokinetic modeling of monoclonal antibodies in pediatric populations using PK-Sim S Basu, YT Lien, V Vozmediano, JF Schlender, T Eissing, S Schmidt, ... Frontiers in pharmacology 11, 868, 2020 | 30 | 2020 |
| In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris U Caballero, S Kim, E Eraso, G Quindós, V Vozmediano, S Schmidt, ... Antibiotics 10 (4), 355, 2021 | 27 | 2021 |
| Vancomycin in peritoneal dialysis: clinical pharmacology considerations in therapy E Lam, YT Lien, WK Kraft, B Piraino, V Vozmediano, S Schmidt, J Zhang Peritoneal Dialysis International 40 (4), 384-393, 2020 | 23 | 2020 |
| Model informed pediatric development applied to bilastine: ontogenic PK model development, dose selection for first time in children and PK study design V Vozmediano, A Sologuren, JC Lukas, N Leal, M Rodriguez Pharmaceutical Research 34, 2720-2734, 2017 | 21 | 2017 |
| Current strategies to streamline pharmacotherapy for older adults JF Schlender, V Vozmediano, AG Golden, M Rodriguez, TS Samant, ... European Journal of Pharmaceutical Sciences 111, 432-442, 2018 | 18 | 2018 |
| Establishing a multidisciplinary framework to study drug‐drug interactions of hormonal contraceptives: an invitation to collaborate LJ Lesko, V Vozmediano, JD Brown, A Winterstein, P Zhao, J Lippert, ... CPT: Pharmacometrics & Systems Pharmacology 7 (11), 706-708, 2018 | 17 | 2018 |
| Model-informed pediatric development applied to bilastine: analysis of the clinical PK data and confirmation of the dose selected for the target population V Vozmediano, JC Lukas, E Encinas, S Schmidt, A Sologuren, R Valiente, ... European Journal of Pharmaceutical Sciences 128, 180-192, 2019 | 16 | 2019 |
| Genotype-guided dosing of warfarin through modeling and simulation J Deng, V Vozmediano, M Rodriguez, LH Cavallari, S Schmidt European Journal of Pharmaceutical Sciences 109, S9-S14, 2017 | 16 | 2017 |
| Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria M Rodríguez, V Vozmediano, A García-Bea, Z Novák, A Yáñez, C Campo, ... European Journal of Pediatrics 179, 801-805, 2020 | 13 | 2020 |
| Integration of preclinical and clinical knowledge to predict intravenous PK in human: Bilastine case study V Vozmediano, I Ortega, JC Lukas, A Gonzalo, M Rodriguez, ML Lucero European journal of drug metabolism and pharmacokinetics 39, 33-41, 2014 | 13 | 2014 |
| Real‐world data approaches for early detection of potential safety and effectiveness signals for generic substitution: a metoprolol extended‐release case study JD Brown, C Henriksen, V Vozmediano, S Schmidt The Journal of Clinical Pharmacology 59 (9), 1275-1284, 2019 | 12 | 2019 |
| Evaluation of fentanyl disposition and effects in newborn piglets as an experimental model for human neonates C Rey-Santano, V Mielgo, A Valls-i-Soler, E Encinas, JC Lukas, ... PloS one 9 (3), e90728, 2014 | 12 | 2014 |
| Quantitative assessment of levonorgestrel binding partner interplay and drug‐drug interactions using physiologically based pharmacokinetic modeling B Cicali, K Lingineni, R Cristofoletti, T Wendl, J Hoechel, H Wiesinger, ... CPT: Pharmacometrics & Systems Pharmacology 10 (1), 48-58, 2021 | 11 | 2021 |
| Incorporating pharmacometrics into pharmacoeconomic models: applications from drug development M Srinivasan, A White, A Chaturvedula, V Vozmediano, S Schmidt, ... Pharmacoeconomics 38, 1031-1042, 2020 | 11 | 2020 |
| Application of a dual mechanistic approach to support bilastine dose selection for older adults C Kim, V Lo Re, M Rodriguez, JC Lukas, N Leal, C Campo, A García‐Bea, ... CPT: Pharmacometrics & Systems Pharmacology 10 (9), 1006-1017, 2021 | 10 | 2021 |
| Pharmacometrics, Physiologically Based Pharmacokinetics, Quantitative Systems Pharmacology—What's Next?—Joining Mechanistic and Epidemiological Approaches S Schmidt, S Kim, V Vozmediano, R Cristofoletti, AG Winterstein, ... CPT: Pharmacometrics & Systems Pharmacology 8 (6), 352-355, 2019 | 10 | 2019 |
| Quantitative determination of fentanyl in newborn pig plasma and cerebrospinal fluid samples by HPLC‐MS/MS ME Blanco, E Encinas, O González, E Rico, V Vozmediano, E Suárez, ... Drug testing and analysis 7 (9), 804-811, 2015 | 10 | 2015 |
| Acetaminophen protein adducts in hospitalized children receiving multiple doses of acetaminophen S Jiang, V Vozmediano, SM Abdel‐Rahman, S Schmidt, LP James The Journal of Clinical Pharmacology 59 (10), 1291-1299, 2019 | 9 | 2019 |
| Evaluating the clinical impact of formulation variability: a metoprolol extended‐release case study S Kim, VD Sharma, K Lingineni, N Farhan, L Fang, L Zhao, JD Brown, ... The Journal of Clinical Pharmacology 59 (9), 1266-1274, 2019 | 9 | 2019 |
